RAD51 and XRCC2 Genetics Variants and Multiple Myeloma Risk, Chromosomal Aberrations, and Clinical Outcomes

Authors: Popek-Marciniec, Sylwia; Styk, Wojciech; Sienkiewicz, Kinga; Chocholska, Sylwia; Szudy-Szczyrek, Aneta; Hus, Marek; Czerwik-Marcinkowska, Joanna; Swiderska-Kolacz, Grazyna; Pietras, Tadeusz; Zmorzynski, Szymon

Source journal: The application of clinical genetics (2026-01-01)

DOI: 10.2147/TACG.S601102

Abstract

BACKGROUND: Multiple myeloma (MM) is a hematologic malignancy characterized by genomic instability, frequently involving chromosomal translocations and deletions. Such abnormalities often result from DNA double-stranded breaks. RAD51 and XRCC2 gene products play key roles in the homologous recombination repair of these breaks. PURPOSE: In this study, we investigated the role of selected genetic variants in MM pathogenesis and progression. Specifically, we analyzed two RAD51 polymorphisms (rs1801321 - 172G>T and rs1801320 - 135G>C) and one in XRCC2 (rs3218536 - Arg188His). The RAD51 variants are located in the 5' untranslated region and may affect gene regulation or expression, whereas the XRCC2 rs3218536 variant results in an amino acid substitution that may influence protein function. The study aimed to evaluate the associations between these variants and chromosomal aberrations (deletions/translocations), the risk of developing MM, and treatment response. PATIENTS AND METHODS: Genomic DNA extracted from 117 newly diagnosed MM patients and 187 healthy blood donors was used to analyze RAD51 and XRCC2 variants (via real-time PCR). The method of cIg-FISH was applied for analysis of chromosomal aberrations. Gene-expression analysis was performed in 85 patient samples from which sufficient high-quality RNA was obtained from isolated CD138-positive plasma cells. RESULTS: The T allele of RAD51 rs1801321 was associated with a significantly reduced risk of MM (OR = 0.52, 95% CI: 0.37-0.73, p < 0.001). However, RAD51 rs1801320 and XRCC2 rs3218536 showed no association with MM susceptibility. None of the studied variants were found to correlate with chromosomal aberrations or overall survival. Exploratory analyses showed that the rs1801321 T allele and the RAD51 rs1801320 GG genotype were associated with higher XRCC2 expression. CONCLUSION: The RAD51 rs1801321 T allele was associated with lower MM susceptibility in the present cohort. However, RAD51 rs1801320 and XRCC2 rs3218536 do not appear to have a significant impact on chromosomal aberrations, disease progression or treatment response.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.